High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19

Using a high throughput, random bacterial peptide display approach applied to patient serum samples, Haynes, Kamath, Bozekowski et al identify the antigens and epitopes that elicit a SARS-CoV-2 humoral response. They identify differences depending on disease severity and further in silico analysis s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Winston A. Haynes, Kathy Kamath, Joel Bozekowski, Elisabeth Baum-Jones, Melissa Campbell, Arnau Casanovas-Massana, Patrick S. Daugherty, Charles S. Dela Cruz, Abhilash Dhal, Shelli F. Farhadian, Lynn Fitzgibbons, John Fournier, Michael Jhatro, Gregory Jordan, Jon Klein, Carolina Lucas, Debra Kessler, Larry L. Luchsinger, Brian Martinez, M. Catherine Muenker, Lauren Pischel, Jack Reifert, Jaymie R. Sawyer, Rebecca Waitz, Elsio A. Wunder, Minlu Zhang, Yale IMPACT Team, Akiko Iwasaki, Albert Ko, John C. Shon
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/35fd28046b3d4061a1a0e849a204b9bb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:35fd28046b3d4061a1a0e849a204b9bb
record_format dspace
spelling oai:doaj.org-article:35fd28046b3d4061a1a0e849a204b9bb2021-11-28T12:10:25ZHigh-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-1910.1038/s42003-021-02835-22399-3642https://doaj.org/article/35fd28046b3d4061a1a0e849a204b9bb2021-11-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-02835-2https://doaj.org/toc/2399-3642Using a high throughput, random bacterial peptide display approach applied to patient serum samples, Haynes, Kamath, Bozekowski et al identify the antigens and epitopes that elicit a SARS-CoV-2 humoral response. They identify differences depending on disease severity and further in silico analysis suggests decreased epitope signal for Q677P but not for D614G mutant SARSCoV-2 strains.Winston A. HaynesKathy KamathJoel BozekowskiElisabeth Baum-JonesMelissa CampbellArnau Casanovas-MassanaPatrick S. DaughertyCharles S. Dela CruzAbhilash DhalShelli F. FarhadianLynn FitzgibbonsJohn FournierMichael JhatroGregory JordanJon KleinCarolina LucasDebra KesslerLarry L. LuchsingerBrian MartinezM. Catherine MuenkerLauren PischelJack ReifertJaymie R. SawyerRebecca WaitzElsio A. WunderMinlu ZhangYale IMPACT TeamAkiko IwasakiAlbert KoJohn C. ShonNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Winston A. Haynes
Kathy Kamath
Joel Bozekowski
Elisabeth Baum-Jones
Melissa Campbell
Arnau Casanovas-Massana
Patrick S. Daugherty
Charles S. Dela Cruz
Abhilash Dhal
Shelli F. Farhadian
Lynn Fitzgibbons
John Fournier
Michael Jhatro
Gregory Jordan
Jon Klein
Carolina Lucas
Debra Kessler
Larry L. Luchsinger
Brian Martinez
M. Catherine Muenker
Lauren Pischel
Jack Reifert
Jaymie R. Sawyer
Rebecca Waitz
Elsio A. Wunder
Minlu Zhang
Yale IMPACT Team
Akiko Iwasaki
Albert Ko
John C. Shon
High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19
description Using a high throughput, random bacterial peptide display approach applied to patient serum samples, Haynes, Kamath, Bozekowski et al identify the antigens and epitopes that elicit a SARS-CoV-2 humoral response. They identify differences depending on disease severity and further in silico analysis suggests decreased epitope signal for Q677P but not for D614G mutant SARSCoV-2 strains.
format article
author Winston A. Haynes
Kathy Kamath
Joel Bozekowski
Elisabeth Baum-Jones
Melissa Campbell
Arnau Casanovas-Massana
Patrick S. Daugherty
Charles S. Dela Cruz
Abhilash Dhal
Shelli F. Farhadian
Lynn Fitzgibbons
John Fournier
Michael Jhatro
Gregory Jordan
Jon Klein
Carolina Lucas
Debra Kessler
Larry L. Luchsinger
Brian Martinez
M. Catherine Muenker
Lauren Pischel
Jack Reifert
Jaymie R. Sawyer
Rebecca Waitz
Elsio A. Wunder
Minlu Zhang
Yale IMPACT Team
Akiko Iwasaki
Albert Ko
John C. Shon
author_facet Winston A. Haynes
Kathy Kamath
Joel Bozekowski
Elisabeth Baum-Jones
Melissa Campbell
Arnau Casanovas-Massana
Patrick S. Daugherty
Charles S. Dela Cruz
Abhilash Dhal
Shelli F. Farhadian
Lynn Fitzgibbons
John Fournier
Michael Jhatro
Gregory Jordan
Jon Klein
Carolina Lucas
Debra Kessler
Larry L. Luchsinger
Brian Martinez
M. Catherine Muenker
Lauren Pischel
Jack Reifert
Jaymie R. Sawyer
Rebecca Waitz
Elsio A. Wunder
Minlu Zhang
Yale IMPACT Team
Akiko Iwasaki
Albert Ko
John C. Shon
author_sort Winston A. Haynes
title High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19
title_short High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19
title_full High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19
title_fullStr High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19
title_full_unstemmed High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19
title_sort high-resolution epitope mapping and characterization of sars-cov-2 antibodies in large cohorts of subjects with covid-19
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/35fd28046b3d4061a1a0e849a204b9bb
work_keys_str_mv AT winstonahaynes highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT kathykamath highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT joelbozekowski highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT elisabethbaumjones highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT melissacampbell highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT arnaucasanovasmassana highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT patricksdaugherty highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT charlessdelacruz highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT abhilashdhal highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT shelliffarhadian highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT lynnfitzgibbons highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT johnfournier highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT michaeljhatro highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT gregoryjordan highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT jonklein highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT carolinalucas highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT debrakessler highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT larrylluchsinger highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT brianmartinez highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT mcatherinemuenker highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT laurenpischel highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT jackreifert highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT jaymiersawyer highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT rebeccawaitz highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT elsioawunder highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT minluzhang highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT yaleimpactteam highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT akikoiwasaki highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT albertko highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
AT johncshon highresolutionepitopemappingandcharacterizationofsarscov2antibodiesinlargecohortsofsubjectswithcovid19
_version_ 1718408130089451520